CG
TMDX icon

Caprock Group’s Transmedics TMDX Stock Holding History

Caprock Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,312
Closed -$230K – 1318
2026
Q1 		$230K Buy
2,312
+295
+15% +$38.5K 0.01% 1008
2025
Q4 		$245K Buy
+2,017
New +$253K 0.01% 1054

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Caprock Group's TMDX Position: Q2 2026 in Review

Caprock Group sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 2,312 shares — an estimated $230K sold.

Caprock Group first reported a position in TMDX in Q4 2025 and held it in 2 quarters. The position peaked at $245K in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Caprock Group reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Caprock Group sold 2,312 Transmedics shares in Q2 2026, an estimated $230K.
  • Caprock Group first reported a position in Transmedics in Q4 2025 and held it in 2 quarters.
  • Caprock Group's Transmedics position peaked at $245K in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.